GENE ONLINE|News &
Opinion
Blog

Generic Drug
Investigate the Current Status of Rivaroxaban Generic Drug Application in China
2023-03-01
If It Works, Replicate It: Generic COVID-19 Drugs
2022-03-28
First Generic for Dry-eye Gets U.S. FDA Nod
2022-02-04
China Drugmaker Aims for First Generic Drug Approval of Novartis’ Tasigna in China
2021-09-24
Mainstream Generic Drugs Become Stumbling Blocks for Drug Innovation: A Deepdive into China’s Patent Trends
2021-03-17
Perrigo Splits Businesses, Offloads Generic Division to Private Equity
2021-03-04
Taiwan’s TTY Biopharm Pushes for Clinical Trials of its Complex Cancer Generic Drugs in Europe
2021-02-10
LATEST
Biogen’s Tofersen May Show Clinical Benefit in ALS Patients with Rare SOD1 Mutations
2023-03-21
Comparing ESG Regulations in the U.S., the U.K., and the EU
2023-03-21
See-Mode Technologies Secures Regulatory Approvals for its AI-powered Software that Automatically Analyses and Reports Breast & Thyroid Ultrasound Scans in Australia and New Zealand
2023-03-21
OncoC4 Bags $200 Million In CTLA-4 Antibody Pact With BioNTech
2023-03-21
HHS Issues Initial Guidance on Negotiation Program as Government’s Latest Move to Reduce Drug Prices
2023-03-21
First-Ever Insect Brain Neuron Map Completed
2023-03-21
AbbVie Unveils Latest Data For Skyrizi In Difficult-To-Treat Psoriasis
2023-03-20
Scroll to Top